Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antibacterials - Johnson & Johnson

Drug Profile

Research programme: antibacterials - Johnson & Johnson

Alternative Names: ARQ 259034; C6-carbamate ketolides research programme - Johnson & Johnson; DQ-1; JNJ 10275798; JNJ 10278385; JNJ 17069546; JNJ 6333314; JNJ-Q1; MurF inhibitors - Johnson & Johnson; RWJ 670963

Latest Information Update: 04 Nov 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Johnson & Johnson Pharmaceutical Research & Development
  • Class Fluoroquinolones; Ketolides; Small molecules
  • Mechanism of Action Cell wall inhibitors; DNA gyrase inhibitors; DNA topoisomerase IV inhibitors; MurF synthetase inhibitors; Protein 50S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Bacterial infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in USA
  • 31 May 2010 Antimicrobial data from an in vitro study in Bacterial infections released by Johnson & Johnson Pharmaceutical Research & Development
  • 31 May 2010 Preclinical development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top